MARKET

SIBN

SIBN

SI-BONE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.56
-0.41
-3.74%
After Hours: 10.56 0 0.00% 16:00 04/03 EDT
OPEN
11.03
PREV CLOSE
10.97
HIGH
11.22
LOW
10.20
VOLUME
208.23K
TURNOVER
--
52 WEEK HIGH
23.10
52 WEEK LOW
7.20
MARKET CAP
299.74M
P/E (TTM)
-6.7932
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SIBN stock price target is 25.86 with a high estimate of 28.00 and a low estimate of 18.00.

EPS

SIBN News

More
  • More COVID-19 actions - healthcare
  • seekingalpha · 1d ago
  • SI-BONE, Inc. Provides Business Update in Response to COVID-19 Pandemic
  • GlobeNewswire · 1d ago
  • Medical device firms worth a look - Morgan Stanley
  • Seeking Alpha - Article · 03/27 17:32
  • The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment
  • Benzinga · 03/17 15:38

Industry

Medical Equipment, Supplies & Distribution
-0.99%
Healthcare Equipment & Supplies
-1.07%

Hot Stocks

Symbol
Price
%Change

About SIBN

SI-BONE, Inc. is focused on development of medical devices. The Company is engaged in the development, manufacture and commercialization of minimally invasive surgical devices for the treatment of patients with low back symptoms related to certain sacroiliac (SI) joint disorders. The Company offers iFuse Implant System, which provides a minimally invasive surgical solution to fuse the SI joint using patented triangular titanium implants that create an interference fit within the ilium and sacrum. The triangular implant shape, combined with the press fit insertion, is designed to provide fixation by minimizing rotational motion. The implants has a porous surface that provide an environment for bone ongrowth and ingrowth, facilitating long-term fusion of the joint. The iFuse Implant System is intended for sacroiliac fusion for conditions, including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis.
More

Webull offers kinds of SI-Bone Inc stock information, including NASDAQ:SIBN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SIBN stock news, and many more online research tools to help you make informed decisions.